Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
BMJ (Clinical Research Ed.)
|
October 24, 2009
Should healthy volunteers in clinical trials be paid according to risk? Yes
Eleri Jones, Kathleen Liddell
Journal of Law and the Biosciences
|
July 5, 2021
International transfers of health data between the EU and USA: a sector-specific approach for the USA to ensure an 'adequate' level of protection
Laura Bradford, Mateo Aboy, Kathleen Liddell
The Milbank Quarterly
|
August 28, 2025
Policy Options for Antimicrobial Resistance: Exploring Lessons From Environmental Governance
Isaac Weldon, Kathleen Liddell, Kevin Outterson
The New England Journal of Medicine
|
April 29, 2020
Allocating Medical Resources in the Time of Covid-19
Kathleen Liddell, Stevie Martin, Stephanie Palmer
Journal of Law and the Biosciences
|
July 31, 2020
COVID-19 contact tracing apps: a stress test for privacy, the GDPR, and data protection regimes
Laura Bradford, Mateo Aboy, Kathleen Liddell
Journal of Law and the Biosciences
|
June 24, 2021
Standard contractual clauses for cross-border transfers of health data after <i>Schrems II</i>
Laura Bradford, Mateo Aboy, Kathleen Liddell
Journal of Law and the Biosciences
|
October 7, 2021
An empirical study of large, human biobanks: intellectual property policies and financial conditions for access
Matthew Jordan, Johnathon Liddicoat, Kathleen Liddell
Journal of Law and the Biosciences
|
October 6, 2021
Patient data ownership: who owns your health?
Kathleen Liddell, David A Simon, Anneke Lucassen
BMJ (Clinical Research Ed.)
|
June 26, 2004
The human tissue bill and the mental capacity bill
Kathleen Liddell, David K Menon, Ron Zimmern
Nature Biotechnology
|
November 9, 2016
Myriad's impact on gene patents
Mateo Aboy, Kathleen Liddell, Johnathon Liddicoat, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
BMJ (Clinical Research Ed.)
|
October 24, 2009
Should healthy volunteers in clinical trials be paid according to risk? Yes
Eleri Jones, Kathleen Liddell
Journal of Law and the Biosciences
|
July 5, 2021
International transfers of health data between the EU and USA: a sector-specific approach for the USA to ensure an 'adequate' level of protection
Laura Bradford, Mateo Aboy, Kathleen Liddell
The Milbank Quarterly
|
August 28, 2025
Policy Options for Antimicrobial Resistance: Exploring Lessons From Environmental Governance
Isaac Weldon, Kathleen Liddell, Kevin Outterson
The New England Journal of Medicine
|
April 29, 2020
Allocating Medical Resources in the Time of Covid-19
Kathleen Liddell, Stevie Martin, Stephanie Palmer
Journal of Law and the Biosciences
|
July 31, 2020
COVID-19 contact tracing apps: a stress test for privacy, the GDPR, and data protection regimes
Laura Bradford, Mateo Aboy, Kathleen Liddell
Journal of Law and the Biosciences
|
June 24, 2021
Standard contractual clauses for cross-border transfers of health data after <i>Schrems II</i>
Laura Bradford, Mateo Aboy, Kathleen Liddell
Journal of Law and the Biosciences
|
October 7, 2021
An empirical study of large, human biobanks: intellectual property policies and financial conditions for access
Matthew Jordan, Johnathon Liddicoat, Kathleen Liddell
Journal of Law and the Biosciences
|
October 6, 2021
Patient data ownership: who owns your health?
Kathleen Liddell, David A Simon, Anneke Lucassen
BMJ (Clinical Research Ed.)
|
June 26, 2004
The human tissue bill and the mental capacity bill
Kathleen Liddell, David K Menon, Ron Zimmern
Nature Biotechnology
|
November 9, 2016
Myriad's impact on gene patents
Mateo Aboy, Kathleen Liddell, Johnathon Liddicoat, et al.
Page
of 4